Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (4): 1008-1017.doi: 10.13481/j.1671-587X.20230423
• Research in basic medicine • Previous Articles Next Articles
Meng LIU,Xiaodong HUANG,Zheng HAN,Qingxi ZHU,Jie TAN,Xia TIAN(
)
Received:2022-07-11
Online:2023-07-28
Published:2023-07-26
Contact:
Xia TIAN
E-mail:xtian16@sina.cn
CLC Number:
Meng LIU,Xiaodong HUANG,Zheng HAN,Qingxi ZHU,Jie TAN,Xia TIAN. Effect of cadherin-17 on proliferation and apoptosis of colorectal cancer cells and its PI3K/AKT/mTOR signaling pathway regulatory mechanism[J].Journal of Jilin University(Medicine Edition), 2023, 49(4): 1008-1017.
| 1 | BAIDOUN F, ELSHIWY K, ELKERAIE Y, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes[J].Curr Drug Targets,2021,22(9): 998-1009. |
| 2 | DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480. |
| 3 | PIAWAH S, VENOOK A P. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer[J]. Cancer, 2019,125(23):4139-4147. |
| 4 | CASAL J I, BARTOLOMÉ R A. Beyond N-cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and metastasis[J]. Int J Mol Sci, 2019, 20(13): 3373. |
| 5 | LIU M, HAN Z, ZHU Q X, et al. Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells[J]. Cancer Gene Ther, 2018, 25(1/2): 1-9. |
| 6 | LIU X J, HUANG Y, YUAN H, et al. Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death[J]. Cancer Lett, 2019, 454: 204-214. |
| 7 | GARCÍA-MARTÍNEZ J M, WANG S, WEISHAEUPL C, et al. Selective tumor cell apoptosis and tumor regression in CDH17-positive colorectal cancer models using BI 905711, a novel liver-sparing TRAILR2 agonist[J]. Mol Cancer Ther, 2021, 20(1): 96-108. |
| 8 | CASAL J I, BARTOLOMÉ R A. RGD cadherins and α2β1 integrin in cancer metastasis: a dangerous liaison[J]. Biochim Biophys Acta BBA Rev Cancer, 2018, 1869(2): 321-332. |
| 9 | POLIVKA J J R, JANKU F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway[J]. Pharmacol Ther, 2014, 142(2): 164-175. |
| 10 | MBENGUE A, BHATTACHARJEE S, PANDHARKAR T, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria[J]. Nature, 2015, 520(7549): 683-687. |
| 11 | HERTEL N, REDIES C, MEDINA L. Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala[J].J Comp Neurol,2012,520(17): 3982-4012. |
| 12 | BARTOLOMÉ R A, BARDERAS R, TORRES S,et al.Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis[J]. Oncogene, 2014, 33(13): 1658-1669. |
| 13 | TIAN X, LIU M, ZHU Q X, et al. Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells[J]. Expert Rev Anticancer Ther, 2017, 17(9): 857-863. |
| 14 | 韩 峥, 黄晓东, 刘 蒙, 等. 敲低钙黏素17(CDH17)抑制那可丁耐药性SW480人结肠癌细胞的增殖并促进其凋亡[J].细胞与分子免疫学杂志,2017,33(5):606-610. |
| 15 | KACZANOWSKI S. Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging[J]. Phys Biol, 2016, 13(3): 031001. |
| 16 | OBENG E. Apoptosis (programmed cell death) and its signals-A review[J]. Revista Brasleira De Biol, 2021, 81(4): 1133-1143. |
| 17 | LI Z H, GUO D D, YIN X W, et al. Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro [J]. Biomedecine Pharmacother, 2020, 122: 109712. |
| 18 | XU F, NA L X, LI Y F, et al. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours[J]. Cell Biosci, 2020, 10(1): 54. |
| 19 | 肖旭阳, 杜天宇, 周 玄, 等. miR-184对顺铂耐药肺癌细胞PI3K、AKT和mTOR蛋白表达的影响[J].郑州大学学报(医学版),2022,57(3):344-349. |
| 20 | NARAYANANKUTTY A. PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence[J]. Curr Drug Targets, 2019, 20(12): 1217-1226. |
| 21 | STEFANI C, MIRICESCU D, STANESCU-SPINU I I,et al. Growth factors, PI3K/AKT/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now?[J]. Int J Mol Sci, 2021, 22(19): 10260. |
| 22 | DUAN S Y, HUANG W Q, LIU X T, et al. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways[J]. J Exp Clin Cancer Res, 2018, 37(1): 304. |